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1. Introduction 
A protein of an estimated molecular mass (M,) of 
18 000 has been identified as proglucagon in biosyn- 
thetic studies on isolated rat pancreatic islets [ 11. 
Moreover, a 10 000 M, peptide was recognized as a 
major conversion product of this prohormone. The 
intracellular accumulation of this radioactively 
labeled fragment, which was found to be devoid of 
the glucagon sequence, was accompanied by that of 
newly synthesized glucagon [ 11. 
Here, this major proglucagon fragment is identified 
as an abundant peptide in the Coomassie blue-stained 
electrophoretic patterns of rat islet proteins by the 
following criteria: 
(i) Its regional distribution in the rat pancreas 
corresponds to the difference in glucagon biosyn- 
thesis in ‘duodenal’ and ‘splenic’ islets, respec- 
tively; 
(ii) Its electrophoretic and isoelectric characteristics 
are identical to that of the major conversion 
product of [35S]methionine-labeled proglucagon. 
Moreover, secretion of the newly synthesized major 
fragment is found to be stimulated by arginine, its 
release following kinetics similar to that of labeled 
glucagon. These data strongly support the identifica- 
tion of the major proglucagon fragment as an end- 
product, besides glucagon itself, of prohormonal 
proteolytic conversion. 
2. Methods 
2.1. Isolation of pancreatic islets and electrophoretic 
analysis of islet proteins 
Islets were isolated from inbred Wistar rats (200- 
ElsevierlNorth-Holland Biomedical Press 
300 g) by a modified collagenase procedure [2] 
(collagenase type V, Sigma). Incubation of isolated 
islets with [35S]methionine, lysis of islets, sodium 
dodecylsulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) as well as fluorographic detection of 
labeled proteins have been described [3]. For two- 
dimensional analysis 100 islets were suspended in 
40 d lysis buffer [4] followed by repeated freezing 
and thawing and boiling for 3 min. Supernates of 
the centrifuged lysates (1000 X g, 5 min) were 
analyzed as in [4]. 
2.2. Incubation of islets for secretion studies 
For prolonged incubation batches of 300-400 
islets were incubated in 1 .O ml Hank’s buffer equili- 
brated with 95% Os/5% COZ, 2.5 tnM glucose, 1 mg/ml 
bovine serum albumin, ammo acids and vitamins 
according to Eagle’s minimum essential medium [5] 
and 10 mM L-arginine where indicated. Islets were 
stirred constantly by gentle agitation. Media were 
changed hourly after sedimenting islets at 400 X g for 
30 sand removal of supernates. Islets were sedimented 
and lysed at the end of the incubation period. 
2.3. Quantitation of newly synthesized proteins 
For its determination in incubation media the 
major proglucagon fragment was concentrated by 
isoelectric precipitation at pH 5 .O after addition of 
HCl-ethanol extract [6] of 50 islets/medium sample 
as carrier. These precipitates and islet lysates, respec- 
tively, were subjected to SDS-PAGE. From fluoro- 
graphed gels the labeled major proglucagon fragment 
was excised (fig.lc, p) and gel bits were dissolved 
and scintilationcounted [3]. 
For quantitating newly synthesized glucagon 
20 pg synthetic glucagon (Serva), known to be 
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identical to rat glucagon [7], were added as carrier 
to islet lysates and medium samples, respectively. 
From media glucagon was then precipitated in 10% 
trichloroacetic acid. Trichloroacetic acid-precipitates 
and islet lysates were electrophoresed (SDS-PAGE) 
and gels were fixed in acetic acid/methanol (9.2%/ 
45.4%) and dried. The lowermost peptide band 
(i-band, fig. 1) containing small peptides like insulin 
chains and glucagon, was localized by juxtaposition 
of Coomassie blue-stained lanes and excised. Gel bits 
were soaked in lysis buffer [4], chopped into small 
pieces and placed on top of cylindrical gels for iso- 
electric focusing (IEF). After IEF and fixation in 
12% trichloroacetic acid gels were stained with 
Coomassie blue. Heavily stained glucagon bands were 
excised to be then dissolved and scintillation-counted 
Losses of glucagon during this procedure were 
found to be negligible in contrast to its poor preser- 
vation in gels treated for fluorography [I]. 
3. Results and discussion 
The demonstration of equimolar amounts of 
glucagon and the proglucagon fragment in pancreatic 
islets is so far hampered by the unavailability of a 
reliable method for quantitating this fragment. 
Nevertheless, an islet peptide equimolar to glucagon 
is expected to amount to a few micrograms and, 
thus, to form a well visible band in the Coomassie 
blue-stained electrophoretic pattern of proteins of 
100 islets. 
Indeed, a protein of estimated M, 10 000 is con- 
spicuous in stained electrophoretograms of islet 
lysates (fig.la, D). Moreover, this protein is almost 
absent in the pattern of ‘duodenal’ islets (isolated 
from the lower head of the rat pancreas) which have 
been reported to contain only small amounts of 
glucagon as compared to ‘splenic’ islets (isolated from 
the other regions of the pancreas) [8] (fig.la). Com- 
parison of Coomassie blue-stained electrophoresis 
gels with their fluorographs of [ 35S] methionine- 
labeled islet proteins allows for the exact alignment 
of the stained 10 OOOM, protein and the radioactively 
labeled major conversion product of proglucagon 
(fig. 1 b). Again this labeled protein is almost absent 
in ‘duodenal’ islets as well as the other easily dis- 
cernible components of glucagon biosynthesis which 
are the two bands of proglucagon and a likely inter- 
mediate of prohormonal processing of Mr 13 OOO- 
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Fig.1. One-dimensional electrophoretic analysis of rat islet 
proteins: (a) Coomassie blue-stained SDS-PAG electropho- 
retograms of 100 ‘duodenal’ (D) and 100 ‘splenic’ (S) islets, 
respectively. Electrophoretogramsof 3 individualexperiments 
are shown. (b) Left: Coomassie blue-stained SDS-PAG elec- 
trophoretograms of 50 ‘duodenal’ (D) and 50 ‘splenic’ (S) 
islets, respectively, labeled for 2 h with 0.5 nCi [a%]methio- 
nine/islet [ 11. Right: Fluorograph of the same gel; pg, pro- 
glucagon (kfr 18 000); pi, proinsulin (M, 9000); i, insulin 
chains (M, 3000) (c) Left: Fluorograph of electrophoresed 
lysates of 100 randomized islets pulse-labeled for 1 h with 
0.5 nCi [ 35S]methionine/islet and chased for another 2 h 
period either in the absense (-) or in the presence (+) of 
10 mM L-arginine. Right: Electrophoresed and fluorographed 
pH 5.0 precipitates from media of the respective chase incu- 
bations. (D) major proglucagon fragment (MI 10 000). 
Fig.2. Two-dimensional electrophoretic analysis of proteins 
of 100 ‘duodenal’ (D) and 100 ‘splenic’(S) islets, respectively, 
labeled for 2 h with 0.5 PCi [ 35S] methionine/islet. For 
electrophoresis at the second dimension (SDS) lysates of 
50 randomized islets were included as reference samples 
(R). Left: Coomassie bluestained gels. Right: Fluorographs; 
(>) major proglucagon fragment; (*) electrophoretic position 
of proglucagon. 
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Fig.3. Effect of arginine on secretion of the major progluca- 
gon fragment and of glucagon. Batches of 300-400 isolated 
islets were pulselabeled for 1 h with 0.5 @Ci [“%]methio- 
nine/islet [ 11. After washing islets in excess methionine chase 
incubations and subsequent determination of labeled pro- 
teins were performed as in section 2. Symbols refer to 3 
individual experiments: open, chase incubations in the absence 
of additional arginine; closed, chase incubations with 10 mM 
L-a&tine. Top: hatched columns, newly synthesized pro- 
teins in islets at the end of the chase period; light columns, 
labeled proteins released during the 5 h-chase period (sum of 
the data shown below). Bottom: time course of the release 
of the labeled proglucagon fragment and of glucagon, respec- 
tively. 
14 000. Extended documentation on the identifica- 
tion of these and other precursors of islet hormones 
has been presented in [ 1,3,9]. 
The identity of the stained and the radioactively 
labeled 10 000 MI protein is substantiated by two- 
dimensional electrophoretic analysis (fig.2). Both the 
stained and the radioactive peptide occupy the same 
position in the two-dimensional area corresponding 
to an isoelectric point of 4.6 if ‘splenic’ islet lysates 
are analyzed, whereas the corresponding spots on 
plates from ‘duodenal’ islets are almost unvisible 
(fig.2). Although other components of glucagon bio- 
synthesis are hard to be discerned on two-dimensional 
fluorographs an interesting isoelectric heterogeneity 
of labeled material at the expected position of pro- 
glucagon can be observed (fig.2, *) which could be 
due to the so far unidentified post-translational modi- 
fication of proglucagon [ 11. 
Conversion products of proglucagon are supposed 
to be packed into secretory granules to be secreted 
together with glucagon upon application of an appro- 
priate stimulus. For secretion studies batches of islets 
were pulse-labeled with [35S]methionine followed by 
chase periods up to 5 h in the presence of arginine as 
a secretory stimulus. As shown in fig. 1 c and 3 the 
secretion of both glucagon and the major proglucagon 
fragment is stimulated by 10 mM arginine their release 
following similar kinetics and reaching a maximum 
after 3-4 h of incubation (fig.3, bottom). Determina- 
tion of these labeled proteins in lysates of islets at 
the end of secretion experiments gave similar ratios 
of intracellular to released material for both peptides 
(fig.3, top). Since there is almost twice as much radio- 
activity found in the 10 000 Mr protein as compared 
to glucagon it appears that the major fragment con- 
tains 2 methionine residues over 1 residue in rat glu- 
cagon [7]. 
The abundance of the major proglucagon fragment 
in pancreatic islets and its secretion upon stimulation 
by arginine indicate that this fragment is truely an 
endproduct of proglucagon conversion. The physiol- 
ogical significance of this fragment is so far completely 
unknown. A structural relationship between pancreatic 
proglucagon and glicentin, a larger form (M, 12 000) 
of glucagon isolated from intestinal mucosa [lo], has 
been suggested [ 1,101. Accordingly, the major pro- 
glucagon fragment may partly be homologous to that 
portion of glycentin unrelated to the glucagon 
sequence. 
From immunohistochemical studies on pancreatic 
islets the presence of glycentin-related immunoreactiv- 
ity in secretory granules of glucagon-producing A-cells 
has been reported [ 111. Moreover, such immunoreac- 
tive material was found to be secreted together with 
glucagon from the perfused pancreas [ 121. However, 
this released material differed from glycentin itself 
by its smaller size, its more acidic isoelectric point 
of -4, as well as by its lack of glucagon-immuno- 
reactivity [ 121. These findings agree with the present 
data. It therefore appears that the major proglucagon 
fragment represents the glycentin-related material 
released from pancreatic islets. 
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